The 230,000-square-foot facility will add 150 manufacturing jobs with an annual payroll of $10 million. Investment in the facility totals over $165 million, including a capital grant of $10 million from New York state, according to the company.

“This a wonderful example of how a long-term commitment to technology can spur the growth of our manufacturing base and create new high-tech jobs,” said Mark Little, senior vice president and director, GE Global Research, during a June 5 grand opening ceremony. “We spent 15 years developing GE’s revolutionary digital X-ray technology at our Global Research Center in Niskayuna. Today, we celebrate the opening of a new production facility that will manufacture and transfer this innovative technology to all corners of the world.”

While other GE businesses have a long history in New York, this will be the first expansion of high-tech medical equipment manufacturing by GE Healthcare into New York state, the company noted.

“This dedicated mammography manufacturing facility is a great reflection of the company’s commitment to improving access to high-quality health care products worldwide,” said Mike Genau, general manager, diagnostic X-ray, GE Healthcare. “The market continues to be in an important transition period from analog to digital technologies and GE mammography offers some of the highest productivity and workflow efficiency in the industry. Despite the economic slowdown, we expect the global market to grow by 5% over the next few years. This new manufacturing facility will be a great asset for the company to meet the needs of our customers and patients all around the world.”

The building has achieved USGBC LEED Gold Certification, making it one of two semiconductor manufacturing facilities in the United States to achieve this status, according to GE Healthcare.

Headquartered in Chalfont St. Giles, United Kingdom, GE Healthcare is a $17 billion unit of General Electric Co., employing more than 46,000 people worldwide.